Concepedia
The Lancet Haematology · 2016 · 117 citations · 25 references
MedicineHematologyOncologyCancer ImmunologyImmunotherapyMedical OncologyB-cell ResponsesCancer ImmunotherapyHematologic Malignancy TherapyB-cell Malignancy TherapyLymphoma Treatment ResponseRituximab-based Therapy
25
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
Mary E. Charlson, Peter Pompei, Kathy L. Aleš et al. · Journal of Chronic Diseases · 1987 · 49.9K citations
Public Health, Biostatistics, Clinical Classification Systems +15
Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living
M. P. Lawton, Elaine Brody · The Gerontologist · 1969 · 18.5K citations
Social Sciences, Psychology, Social Work +12
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Martin M. Oken, Richard H. Creech, Douglass C. Tormey et al. · American Journal of Clinical Oncology · 1982 · 11.6K citations
Pharmacy, Oncology, Medical Oncology +8
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
Bertrand Coiffier, Éric Lepage, Josette Brière et al. · New England Journal of Medicine · 2002 · 5.6K citations · Full text
Medicine, Immunology, Oncology +9
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
Christine P. Hans · Blood · 2003 · 4.3K citations · Full text
Medicine, Oncology, Pathology +16